Resistance to Activation-Induced Cell Death and Bystander Cytotoxicity Via the Fas/Fas Ligand Pathway Are Implicated in the Pathogenesis of Cutaneous T Cell Lymphomas
- 1 April 2005
- journal article
- Published by Elsevier BV in Journal of Investigative Dermatology
- Vol. 124 (4), 741-750
- https://doi.org/10.1111/j.0022-202x.2005.23657.x
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- Infrequent Fas Mutations but No Bax or p53 Mutations in Early Mycosis Fungoides: A Possible Mechanism for the Accumulation of Malignant T Lymphocytes in the SkinJournal of Investigative Dermatology, 2002
- The death of a T-cell: expression of the CD95 ligandCell Death & Differentiation, 2002
- ‘Activation-induced cell death’: a special program able to preserve the homeostasis of the skin?Experimental Dermatology, 2002
- The role of Fas ligand in immune privilegeNature Reviews Molecular Cell Biology, 2001
- Comparison of Fas(Apo-1/CD95)- and perforin-mediated cytotoxicity in primary T lymphocytesInternational Immunology, 1996
- Metalloproteinase-mediated release of human Fas ligand.The Journal of Experimental Medicine, 1995
- Fas Ligand-Induced Apoptosis as a Mechanism of Immune PrivilegeScience, 1995
- Superantigenic Staphylococcal Exotoxins Induce T-Cell Proliferation in the Presence of Langerhans Cells or Class II–Bearing Keratinocytes and Stimulate Keratinocytes to Produce T-Cell–Activating CytokinesJournal of Investigative Dermatology, 1994
- Treatment of erythrodermic cutaneous T-cell lymphoma with extracorporeal photochemotherapyJournal of the American Academy of Dermatology, 1992
- Mycosis Fungoides in the United StatesJAMA, 1988